Copied
 
 
2016, DKK
29.05.2017
Bruttoresultat
Na.
Primær drift
Na.
Årets resultat

-2.957'

Aktiver

170''

Kortfristede aktiver
Na.
Egenkapital

158''

Afkastningsgrad

0 %

Soliditetsgrad

93 %

Likviditetsgrad

0 %

Resultat
29.05.2017
Årsrapport
2016
29.05.2017
2015
13.07.2016
Nettoomsætning7.650.584
Resultat af primær drift0-2.913.240
Indtægter af kapitalandele (tilknyttede og associerede) 00
Finansielle indtægter00
Finansieringsomkostninger-253.888-2.358.610
Andre finansielle omkostninger00
Resultat før skat-6.027.009-5.278.335
Resultat-2.956.616-2.497.914
Forslag til udbytte00
Aktiver
29.05.2017
Årsrapport
2016
29.05.2017
2015
13.07.2016
Kortfristede varebeholdninger00
Kortfristede tilgodehavender fra salg og tjenesteydelser 457.476193.414
Likvider2.741.9532.109.583
Kortfristede aktiver02.302.997
Immaterielle aktiver og goodwill165.223.601160.814.479
Finansielle anlægsaktiver628.823638.264
Materielle aktiver634.372364.278
Langfristede aktiver166.486.796161.817.021
Aktiver169.686.225164.120.018
Aktiver
29.05.2017
Passiver
29.05.2017
Årsrapport
2016
29.05.2017
2015
13.07.2016
Forslag til udbytte00
Egenkapital158.494.656161.451.273
Hensatte forpligtelser00
Langfristet gæld til banker00
Anden langfristet gæld00
Leverandører af varer og tjenesteydelser1.178.0321.567.869
Kortfristede forpligtelser02.668.745
Gældsforpligtelser11.191.5692.668.745
Forpligtelser11.191.5692.668.745
Passiver169.686.225164.120.018
Passiver
29.05.2017
Nøgletal
29.05.2017
Årsrapport
2016
29.05.2017
2015
13.07.2016
Afkastningsgrad Na.-1,8 %
Dækningsgrad
Resultatgrad -38,6 %Na.
Varelagerets omsætningshastighed Na.Na.
Egenkapitals-forretning -1,9 %-1,5 %
Payout-ratio Na.Na.
Gældsdæknings-nøgletal Na.-123,5 %
Soliditestgrad 93,4 %98,4 %
Likviditetsgrad Na.86,3 %
Resultat
29.05.2017
Gæld
29.05.2017
Årsrapport
29.05.2017
Nyeste:01.01.2016- 31.12.2016(offentliggjort: 29.05.2017)
Oplysning om pantsætninger og sikkerhedsstillelser:Mortgages and collateralThe company has not placed any assets or other as security for loans at 31 December 2016.
Beretning
29.05.2017
Dato for ledelsens godkendelse af årsrapporten:2017-05-09
Ledelsespåtegning:Statement by Management on the annual report
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The Board of Directors and the Executive Board have today discussed and approved the annual report of Atonomics A/S for the financial year 1 January – 31 December 2016.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Atonomics' mission is to develop professional quality, low cost diagnostics so that consumers and their health care providers can monitor health and disease from home – reducing costs, improving disease outcomes and optimizing well-being. Atonomics' product, to be known as Trace® is a small, portable diagnostic instrument (a small box the size of a smart phone) that utilizes advanced technologies to read finger stick whole blood samples using standard professional assay reagents. Each biomarker assay is integrated into a single capsule and disposed of after use. Due to its unique technology and elegant workflow, the device delivers exceptional professional quality data with dramatically lower costs than existing diagnostic devices (retail price to be less than <Eur150 for the device and biomarker capsules each at Eur10-12,-). This unlocks largely untapped emerging markets in diagnostics and health monitoring underlined by the increasing wellness and diagnostic monitoring by consumers themselves in the comfort of their own home. The company estimates the total market for consumer diagnostics currently to be at c. $3bn p. a. with the potential to grow further as people start to accept in-home diagnostics as part of their daily life; the company believes it is in a unique position versus other diagnostics manufactures to capitalize on this opportunity driven by its clear technology USPs.